Wynn Capital, LLC Novo Nordisk A S Transaction History
Wynn Capital, LLC
- $168 Billion
- Q1 2025
A detailed history of Wynn Capital, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Wynn Capital, LLC holds 7,090 shares of NVO stock, worth $501,475. This represents 0.29% of its overall portfolio holdings.
Number of Shares
7,090
Previous 7,045
0.64%
Holding current value
$501,475
Previous $606 Million
18.76%
% of portfolio
0.29%
Previous 0.38%
Shares
5 transactions
Others Institutions Holding NVO
# of Institutions
1,769Shares Held
330MCall Options Held
11.3MPut Options Held
15.5M-
Jennison Associates LLC18.8MShares$1.33 Billion0.93% of portfolio
-
Bank Of America Corp Charlotte, NC14.8MShares$1.05 Billion0.08% of portfolio
-
Loomis Sayles & CO L P12.4MShares$876 Million1.24% of portfolio
-
Morgan Stanley New York, NY12.3MShares$871 Million0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa11.9MShares$840 Million0.36% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $160B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...